Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

79 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Circulating tumor cells are an indicator for the administration of adjuvant transarterial chemoembolization in hepatocellular carcinoma: A single-center, retrospective, propensity-matched study.
Wang PX, Sun YF, Zhou KQ, Cheng JW, Hu B, Guo W, Yin Y, Huang JF, Zhou J, Fan J, Cheung TT, Qu XD, Yang XR. Wang PX, et al. Among authors: qu xd. Clin Transl Med. 2020 Jul;10(3):e137. doi: 10.1002/ctm2.137. Epub 2020 Jul 23. Clin Transl Med. 2020. PMID: 32702202 Free PMC article.
Elevated soluble programmed death-ligand 1 levels indicate immunosuppression and poor prognosis in hepatocellular carcinoma patients undergoing transcatheter arterial chemoembolization.
Ma XL, Qu XD, Yang WJ, Wang BL, Shen MN, Zhou Y, Zhang CY, Sun YF, Chen JW, Hu B, Gong ZJ, Zhang X, Pan BS, Zhou J, Fan J, Yang XR, Guo W. Ma XL, et al. Among authors: qu xd. Clin Chim Acta. 2020 Dec;511:67-74. doi: 10.1016/j.cca.2020.09.026. Epub 2020 Sep 24. Clin Chim Acta. 2020. PMID: 32979338
Conversion therapy for initially unresectable hepatocellular carcinoma using a combination of toripalimab, lenvatinib plus TACE: real-world study.
Qu WF, Ding ZB, Qu XD, Tang Z, Zhu GQ, Fu XT, Zhang ZH, Zhang X, Huang A, Tang M, Tian MX, Jiang XF, Huang R, Tao CY, Fang Y, Gao J, Wu XL, Zhou J, Fan J, Liu WR, Shi YH. Qu WF, et al. Among authors: qu xd. BJS Open. 2022 Sep 2;6(5):zrac114. doi: 10.1093/bjsopen/zrac114. BJS Open. 2022. PMID: 36125345 Free PMC article.
Hepatectomy After Conversion Therapy Using Tyrosine Kinase Inhibitors Plus Anti-PD-1 Antibody Therapy for Patients with Unresectable Hepatocellular Carcinoma.
Zhu XD, Huang C, Shen YH, Xu B, Ge NL, Ji Y, Qu XD, Chen L, Chen Y, Li ML, Zhu JJ, Tang ZY, Zhou J, Fan J, Sun HC. Zhu XD, et al. Among authors: qu xd. Ann Surg Oncol. 2023 May;30(5):2782-2790. doi: 10.1245/s10434-022-12530-z. Epub 2022 Sep 30. Ann Surg Oncol. 2023. PMID: 36178565 Free PMC article.
Emergent hybrid-dual-graft liver transplantation: a life-saving strategy for a patient with inadequate living donor graft during the COVID-19 pandemic.
Xiao Y, Huang X, Shi Y, Wang Z, Wang X, He Y, Wang T, Sun J, Song K, Ding Z, Shen Y, Peng Y, Shen Z, Yu L, Zhu K, Li H, Zhou D, Miao C, Ji Y, Yang L, Hou Y, Qu X, Fan J, Zhou J. Xiao Y, et al. Hepatobiliary Surg Nutr. 2022 Oct;11(5):785-788. doi: 10.21037/hbsn-22-335. Hepatobiliary Surg Nutr. 2022. PMID: 36268249 Free PMC article. No abstract available.
[No title available]
[No authors listed] [No authors listed] PMID: 36869918
Macro CD5L+ deteriorates CD8+T cells exhaustion and impairs combination of Gemcitabine-Oxaliplatin-Lenvatinib-anti-PD1 therapy in intrahepatic cholangiocarcinoma.
Lu JC, Wu LL, Sun YN, Huang XY, Gao C, Guo XJ, Zeng HY, Qu XD, Chen Y, Wu D, Pei YZ, Meng XL, Zheng YM, Liang C, Zhang PF, Cai JB, Ding ZB, Yang GH, Ren N, Huang C, Wang XY, Gao Q, Sun QM, Shi YH, Qiu SJ, Ke AW, Shi GM, Zhou J, Sun YD, Fan J. Lu JC, et al. Among authors: qu xd. Nat Commun. 2024 Jan 20;15(1):621. doi: 10.1038/s41467-024-44795-1. Nat Commun. 2024. PMID: 38245530 Free PMC article.
79 results